← All verdicts
Verdict

Data Unavailable

Every analyzed stock in Data Unavailable — 2,921 companies. Each card shows price, our model's intrinsic value (IV), and how far price sits above or below it. Click any card for the full analysis. This is a research-triage view, not a buy/sell signal.

Educational use only — not investment advice. "Undervalued / fairly valued / overvalued" and every risk score reflect our models vs. price, which can be wrong or based on stale or incomplete data. Always review the company's own financials and SEC filings, and consult a licensed advisor, before acting.
"Data Unavailable" by: Model value (price vs DCF) Owner-earnings return (equity bond)

This lens: price against our probability-weighted DCF value (P/IV). Its own forward record began accruing on 2026-09-10 (daily snapshots); until a year of it exists, the panel below tests the nearest cousin we can measure point-in-time — cheap on book value — and says so.

Market state today: Calm — the S&P 500 closed 3.1% below its 1-year high (as of 2026-09-16). Our rule, the same one used to split every backtest on this site: sell-off = 10% or more below the 1-year high, borderline from 5%, calm otherwise. A further 7.2% fall from here would put us in a sell-off. Since 2006 the market has been in a sell-off 16.6% of the time, across 13 episodes (red bands).
2007200920112013201520172019202120232025
S&P 500 (SPY, adjusted) distance from its trailing 1-year high, weekly. Amber band: borderline (−5% to −10%). Red band: sell-off (below −10%). The dot is today. History to 2026-08-19 from the research database; today from the live feed.
Backtest · point in time · 8,702 entries in the study

Does this screen work? The record for exactly these filters

Screen tested: Proxy: price-to-book ≤ 1.2 (undervalued band has no point-in-time history yet) · bought the day of the annual report, held 12 months
Probable Buy every company that met this screen on the day it filed its annual report, hold 12 months: on average it beat the S&P 500 by +12.6 pts (1,427 entries, 311 companies, very unlikely to be luck). 50% of entries beat the S&P; 25% beat it by 30 points or more; 30% trailed it by 20 points or more. Owning everything instead averaged +1.7 pts, so the screen's edge is +10.9 pts.
+12.6 ptsvs S&P, average
50%beat the S&P
25%up 30+ pts vs S&P
30%down 20+ pts vs S&P
+14.0 ptsvs small caps, 12 mo
−15.1 pts 2019worst year to buy ?
6.1luck check ?
Does the holding period matter?3 mo: +2.3 pts 49% beat6 mo: +4.6 pts 49% beat12 mo: +12.6 pts 50% beat24 mo: +21.8 pts 46% beat3 yr, per yr: +1.3 pts 40% beat
Market state at entryCompany-yearsvs S&P 12 movs small caps
Calm ◀ today1,245+7.9 pts t 4.6+10.1 pts
Sell-off (S&P ≥10% off high)182+44.5 pts t 4.0+40.7 pts
Sector (SEC group)nvs S&P 12 mo3 yrs / yr
Industrials & manufacturing466+13.0 pts t 4.0−2.2 pts
Energy126+7.4 pts t 1.2−7.8 pts
Other115+8.4 pts t 1.8+3.8 pts
Tech hardware & semis113+10.9 pts t 1.6+2.3 pts
Services96+11.9 pts t 2.7+12.2 pts
Retail & consumer87+17.2 pts t 2.1+10.2 pts
Finance & real estate72−1.7 pts t -0.5−2.4 pts
Utilities65+5.6 pts t 0.6−1.2 pts
Construction53+13.2 pts t 1.7−2.4 pts
Biotech & pharma44+47.1 pts t 1.6+10.0 pts
Telecom & media43+14.0 pts t 0.7−6.3 pts
Software & IT services35+39.9 pts t 1.8+1.2 pts

Holds up out of sample? Before 2018: +10.7 pts (n 629, t 6.0). From 2018: +14.0 pts (n 798, t 4.1). Same sign in both halves.

Year2010201120122013201420152016201720182019202020212022202320242025
vs S&P+13 pts+5 pts+14 pts+18 pts−4 pts−4 pts+22 pts+12 pts−3 pts−15 pts+87 pts+8 pts+17 pts−9 pts−7 pts+15 pts
n254310610178841118178991297276108121115

Read the research behind this screen: Price-to-book still sorts, across all sizes → · Test your own combination in the Screen Lab →

Our model values are recomputed daily but were never stored historically, so this band cannot be backtested honestly yet. Daily snapshots began 2026-09-10; a true record accrues from there. Until then the nearest tested cousin is shown — cheap on book value — and labelled as a proxy. Point-in-time: each entry is one company bought at the first close after its 10-K filing date, using only filings available that day, held 12 months; result = total return minus SPY over the same months (vs IWM for 12 months; 3-yr annualised). Survivorship-tilted universe; no costs; read spreads, not levels. Educational, hypothetical, before costs.

Sort by: A–Z Riskiest Most overvalued Most shorted Buyers' strike Largest
V
VISA INC.
Valuation N/A
Technology
Price$370.45
Model IV—
P/IV—
Limited data — see page
VBIO
Valion Bio, Inc.
Valuation N/A
Healthcare Risk 37 · Moderate
Price$2.26
Model IV—
P/IV—
Market implies +19.3%/yr vs model +15.0% · above model
VECO
VEECO INSTRUMENTS INC
Valuation N/A
Industrials Risk 43 · Elevated
Price$44.83
Model IV—
P/IV—
Market implies +31.7%/yr vs model +3.3% · above model
VEEA
VEEA INC.
Valuation N/A
Technology Risk 42 · Elevated
Price$1.56
Model IV—
P/IV—
Market implies +90.9%/yr vs model +15.0% · above model
VELO
Velo3D, Inc.
Valuation N/A
Industrials Risk 42 · Elevated
Price$10.53
Model IV—
P/IV—
Market implies +115.7%/yr vs model +13.8% · above model
VENU
Venu Holding Corp
Valuation N/A
Communication Services Risk 37 · Moderate
Price$1.74
Model IV—
P/IV—
Market implies +14.8%/yr vs model +19.2% · below model
VERI
Veritone, Inc.
Valuation N/A
Technology Risk 37 · Moderate
Price$1.15
Model IV—
P/IV—
Market implies +24.0%/yr vs model +2.0% · above model
VERU
VERU INC.
Valuation N/A
Healthcare Risk 27 · Moderate
Price$2.44
Model IV—
P/IV—
Market implies +10.6%/yr vs model +15.0% · below model
VERX
Vertex, Inc.
Valuation N/A
Technology
Price$12.26
Model IV—
P/IV—
Limited data — see page
VFF
Village Farms International, Inc.
Valuation N/A
Basic Materials Risk 40 · Elevated
Price$2.88
Model IV—
P/IV—
Market implies +37.8%/yr vs model +0.0% · above model
VFS
VinFast Auto Ltd.
Valuation N/A
Consumer Cyclical Risk 50 · Elevated
Price$3.21
Model IV—
P/IV—
Market implies +44.9%/yr vs model +8.0% · above model
VHUB
VenHub Global, Inc.
Valuation N/A
Industrials Risk 27 · Moderate
Price$0.85
Model IV—
P/IV—
Market implies +69.1%/yr vs model +15.0% · above model
VIAV
VIAVI SOLUTIONS INC.
Valuation N/A
Technology Risk 42 · Elevated
Price$38.75
Model IV—
P/IV—
Market implies +32.1%/yr vs model +2.0% · above model
VICR
VICOR CORP
Valuation N/A
Technology Risk 32 · Moderate
Price$197.91
Model IV—
P/IV—
Market implies +40.4%/yr vs model +5.8% · above model
VIR
Vir Biotechnology, Inc.
Valuation N/A
Healthcare Risk 42 · Elevated
Price$10.62
Model IV—
P/IV—
Market implies +82.0%/yr vs model +2.0% · above model
VIVS
VivoSim Labs, INC.
Valuation N/A
Healthcare Risk 30 · Moderate
Price$0.28
Model IV—
P/IV—
Market implies -7.8%/yr vs model +15.0% · below model
VLN
Valens Semiconductor Ltd.
Valuation N/A
Technology Risk 33 · Moderate
Price$1.66
Model IV—
P/IV—
Market implies +41.4%/yr vs model +2.0% · above model
VNRX
VOLITIONRX LTD
Valuation N/A
Healthcare Risk 76 · High
Price$0.31
Model IV—
P/IV—
Market implies -0.8%/yr vs model +50.0% · below model
VOYG
Voyager Technologies, Inc./DE
Valuation N/A
Consumer Cyclical Risk 46 · Elevated
Price$33.78
Model IV—
P/IV—
Market implies +107.3%/yr vs model +8.0% · above model
VPG
Vishay Precision Group, Inc.
Valuation N/A
Technology Risk 44 · Elevated
Price$60.49
Model IV—
P/IV—
Market implies +23.9%/yr vs model +2.0% · above model
VSA
VisionSys AI Inc
Valuation N/A
Consumer Defensive Risk 27 · Moderate
Price$2.90
Model IV—
P/IV—
Market implies +130.1%/yr vs model +2.0% · above model
VSEE
VSEE HEALTH, INC.
Valuation N/A
Healthcare Risk 36 · Moderate
Price$0.01
Model IV—
P/IV—
Market implies -50.0%/yr vs model +15.0% · below model
VSH
VISHAY INTERTECHNOLOGY INC
Valuation N/A
Technology Risk 54 · Elevated
Price$33.21
Model IV—
P/IV—
Market implies +24.6%/yr vs model +3.0% · above model
VSNT
Versant Media Group, Inc.
Valuation N/A
Communication Services Risk 38 · Moderate
Price$37.19
Model IV—
P/IV—
Limited data — see page
VST
Vistra Corp.
Valuation N/A
Utilities Risk 54 · Elevated
Price$148.38
Model IV—
P/IV—
Limited data — see page
VSTD
Vestand Inc.
Valuation N/A
Consumer Cyclical Risk 40 · Elevated
Price$0.00
Model IV—
P/IV—
Market implies -50.0%/yr vs model +25.2% · below model
VTEX
VTEX
Valuation N/A
Technology Risk 36 · Moderate
Price$3.60
Model IV—
P/IV—
Market implies -50.0%/yr vs model +10.2% · below model
VTGN
Vistagen Therapeutics, Inc.
Valuation N/A
Healthcare Risk 43 · Elevated
Price$0.24
Model IV—
P/IV—
Market implies +40.3%/yr vs model +2.0% · above model
VTVT
vTv Therapeutics Inc.
Valuation N/A
Healthcare
Price$31.97
Model IV—
P/IV—
Limited data — see page
VUZI
Vuzix Corp
Valuation N/A
Technology Risk 44 · Elevated
Price$2.49
Model IV—
P/IV—
Market implies +88.3%/yr vs model +2.0% · above model
VYGR
Voyager Therapeutics, Inc.
Valuation N/A
Healthcare Risk 57 · Elevated
Price$3.19
Model IV—
P/IV—
Market implies +67.5%/yr vs model +2.0% · above model
VYNE
VYNE Therapeutics Inc.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$27.85
Model IV—
P/IV—
Market implies +139.1%/yr vs model +2.0% · above model
W
Wayfair Inc.
Valuation N/A
Consumer Cyclical Risk 72 · High
Price$104.79
Model IV—
P/IV—
Market implies +43.3%/yr vs model +3.0% · above model
WBI
WaterBridge Infrastructure LLC
Valuation N/A
Energy Risk 50 · Elevated
Price$32.29
Model IV—
P/IV—
Limited data — see page
WCC
WESCO INTERNATIONAL INC
Valuation N/A
Industrials Risk 52 · Elevated
Price$334.46
Model IV—
P/IV—
Market implies +57.0%/yr vs model +6.4% · above model
WCT
Wellchange Holdings Co Ltd
Valuation N/A
Technology Risk 47 · Elevated
Price$7.15
Model IV—
P/IV—
Market implies +57.0%/yr vs model +2.0% · above model
WD
Walker & Dunlop, Inc.
Valuation N/A
Financial Services Risk 42 · Elevated
Price$40.11
Model IV—
P/IV—
Market implies +40.9%/yr vs model +2.0% · above model
WDC
WESTERN DIGITAL CORP
Valuation N/A
Technology Risk 40 · Elevated
Price$447.18
Model IV—
P/IV—
Market implies +49.1%/yr vs model +2.0% · above model
WDH
Waterdrop Inc.
Valuation N/A
Financial Services Risk 41 · Elevated
Price$1.02
Model IV—
P/IV—
Market implies +21.5%/yr vs model +3.1% · above model
WEAT
Teucrium Commodity Trust
Valuation N/A
Financial Services Risk 41 · Elevated
Price$26.25
Model IV—
P/IV—
Limited data — see page
WETO
Wetour Robotics Ltd
Valuation N/A
Industrials Risk 35 · Moderate
Price$2.44
Model IV—
P/IV—
Market implies +41.9%/yr vs model +15.0% · above model
WFF
WF Holding Ltd
Valuation N/A
Consumer Cyclical Risk 57 · Elevated
Price$2.03
Model IV—
P/IV—
Market implies +26.0%/yr vs model +14.2% · above model
WGRX
Wellgistics Health, Inc.
Valuation N/A
Consumer Defensive Risk 42 · Elevated
Price$3.03
Model IV—
P/IV—
Market implies +81.3%/yr vs model +15.0% · above model
WHD
Cactus, Inc.
Valuation N/A
Industrials Risk 52 · Elevated
Price$69.54
Model IV—
P/IV—
Limited data — see page
WHLR
Wheeler Real Estate Investment Trust, Inc.
Valuation N/A
Financial Services Risk 40 · Elevated
Price$0.39
Model IV—
P/IV—
Limited data — see page
WHLRD
Wheeler Real Estate Investment Trust, Inc.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$36.05
Model IV—
P/IV—
Limited data — see page
WHLRP
Wheeler Real Estate Investment Trust, Inc.
Valuation N/A
Financial Services Risk 37 · Moderate
Price$9.00
Model IV—
P/IV—
Limited data — see page
WHWK
Whitehawk Therapeutics, Inc.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$4.11
Model IV—
P/IV—
Market implies +74.9%/yr vs model +2.0% · above model
WKEY
Wisekey International Holding S.A.
Valuation N/A
Technology Risk 36 · Moderate
Price$6.36
Model IV—
P/IV—
Limited data — see page
WKHS
Workhorse Group Inc.
Valuation N/A
Consumer Cyclical Risk 42 · Elevated
Price$3.01
Model IV—
P/IV—
Market implies +56.5%/yr vs model +8.0% · above model
WKSP
Worksport Ltd
Valuation N/A
Consumer Cyclical Risk 31 · Moderate
Price$0.46
Model IV—
P/IV—
Market implies +30.5%/yr vs model +8.0% · above model
WOLF
WOLFSPEED, INC.
Valuation N/A
Technology Risk 56 · Elevated
Price$25.92
Model IV—
P/IV—
Market implies +37.4%/yr vs model +9.6% · above model
WPRT
WESTPORT FUEL SYSTEMS INC.
Valuation N/A
Industrials Risk 37 · Moderate
Price$1.84
Model IV—
P/IV—
Market implies +17.1%/yr vs model +2.0% · above model
WRAP
WRAP TECHNOLOGIES, INC.
Valuation N/A
Industrials Risk 27 · Moderate
Price$1.68
Model IV—
P/IV—
Market implies +51.6%/yr vs model +2.0% · above model
WRBY
Warby Parker Inc.
Valuation N/A
Healthcare Risk 34 · Moderate
Price$24.71
Model IV—
P/IV—
Market implies +56.1%/yr vs model +11.9% · above model
WTF
Waton Financial Ltd
Valuation N/A
Financial Services Risk 49 · Elevated
Price$2.60
Model IV—
P/IV—
Market implies +29.9%/yr vs model +13.9% · above model
WTTR
Select Water Solutions, Inc.
Valuation N/A
Energy
Price$20.64
Model IV—
P/IV—
Limited data — see page
WULF
TERAWULF INC.
Valuation N/A
Financial Services Risk 45 · Elevated
Price$16.74
Model IV—
P/IV—
Market implies +98.9%/yr vs model +15.0% · above model
WVE
Wave Life Sciences Ltd.
Valuation N/A
Healthcare Risk 31 · Moderate
Price$4.59
Model IV—
P/IV—
Market implies +90.1%/yr vs model +2.0% · above model
WYFI
WhiteFiber, Inc.
Valuation N/A
Financial Services Risk 42 · Elevated
Price$17.59
Model IV—
P/IV—
Market implies +29.1%/yr vs model +50.0% · below model